Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.235 AUD | +6.82% | +9.30% | +23.68% |
Mar. 18 | Botanix Pharmaceuticals Limited(ASX:BOT) added to S&P/ASX All Ordinaries Index | CI |
Feb. 27 | Botanix Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Sales 2022 | 2.75M 1.79M | Sales 2023 | 3.77M 2.44M | Capitalization | 171M 111M |
---|---|---|---|---|---|
Net income 2022 | -13M -8.43M | Net income 2023 | -9M -5.83M | EV / Sales 2022 | 17.5 x |
Net cash position 2022 | 7.16M 4.64M | Net cash position 2023 | 10.25M 6.64M | EV / Sales 2023 | 42.5 x |
P/E ratio 2022 |
-4.21
x | P/E ratio 2023 |
-16.4
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 85.28% |
1 day | +6.82% | ||
1 week | +9.30% | ||
Current month | +4.44% | ||
3 months | +38.24% | ||
6 months | +67.86% | ||
Current year | +23.68% |
Managers | Title | Age | Since |
---|---|---|---|
Howie McKibbon
CEO | Chief Executive Officer | - | 19-04-30 |
Vincent Ippolito
CHM | Chairman | 65 | 19-05-19 |
Chief Tech/Sci/R&D Officer | 68 | 21-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stewart Washer
BRD | Director/Board Member | 54 | 19-02-20 |
Henry Bosch
BRD | Director/Board Member | - | 16-06-30 |
Vincent Ippolito
CHM | Chairman | 65 | 19-05-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 0.235 | +6.82% | 4 195 251 |
24-04-30 | 0.22 | 0.00% | 2,564,186 |
24-04-29 | 0.22 | +4.76% | 3,268,674 |
24-04-26 | 0.21 | -2.33% | 1,749,101 |
24-04-24 | 0.215 | 0.00% | 1,530,244 |
Delayed Quote Australian S.E., May 01, 2024 at 02:10 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+23.68% | 225M | |
+3.37% | 69.25B | |
+12.55% | 9B | |
-12.75% | 4.96B | |
+42.38% | 4.47B | |
+5.23% | 3.9B | |
+19.66% | 2.45B | |
-19.05% | 2.41B | |
-28.72% | 2.23B | |
+11.13% | 2.02B |
- Stock Market
- Equities
- BOT Stock